Navigation Links
Cellectis Publishes Its Financial Statement for the First Half of 2010
Date:10/15/2010

6336Total revenue6 3135 056Consumables

(1 231)(901)Wages & Salaries

(4 502)(2 908)Other operating expenses

(9 276)(6 752)Tax

(168)(193)Depreciation & Amortization

(139)(221)Total operating expenses(15 316)(10 975)Current operating income/loss(9 003)(5 919)Other non-current income and expenses

4661Operating income (loss)(8 957)(5 858)Financial income

241282Financial expenses

(17)(1)Cost of financing, net225281Income tax

5 2402 810Net operating income (loss)(3 492)(2 767)About CellectisCellectis is a pioneer in the field of genome engineering. The company designs and markets innovative tools -meganucleases. These molecular scissors enable targeted modifications to DNA, with applications in the research, biomanufacturing, agrobiotechnology and therapeutic sectors.

To date, Cellectis has formed over 20 academic research partnerships and has established more than 50 agreements with pharmaceutical laboratories, seed producers and biotech companies across the world. The company holds exclusive rights to a portfolio of over 260 patents granted or pending.

Since 2007, Cellectis has been listed on the NYSE-Euronext Alternext market (code: ALCLS) in Paris and has secured over euro 70 million in funding since inception.

More information at www.cellectis.com

Follow Cellectis on Twitter at www.twitter.com/cellectis

DisclaimerThis press release and the information contained herein do not constitute an offer to sell or subscribe, or a solicitation of an offer to buy or subscribe, for shares in Cellectis in any country. This press release contains forward-looking statements that relate to the Company's objectives. Such forward-looking statements are based on the current expectations and assumptions of the Company's management only and involve risk and uncerta
'/>"/>

SOURCE Cellectis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Study Shows Meganuclease-Driven Targeted Integration Using Cellectis bioresearchs cGPS® CHO-K1 Kit to be Highly Efficient for Drug Discovery
2. Cellectis Bioresearch and Cedarlane Join Forces for the Distribution of cGPS® and cGPS® Custom Kits in Canada
3. Cellectis bioresearch and Helix Biocon Join Forces for the Promotion of cGPS® and cGPS® Custom Kits and Cell Line Engineering Services in India
4. Cellectis bioresearch Announces Establishment of Subsidiary in the US
5. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
6. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
7. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
8. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
9. Franklin & Seidelmann Publishes Complex Podiatry MRI Study
10. Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
11. ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015 ... Analyzers Market by Product (Bioimpedance Analyzers (BIA), Dual-Energy X-ray ... Hydrostatic Weighing) - Global Analysis & Forecast to 2019", ... was pegged at $911.1 Million 2014 and is estimated ... a CAGR of 9.4% from 2014 to 2019. ...
(Date:7/30/2015)... July 30, 2015  ResMed (NYSE: ... a definitive agreement to acquire Curative Medical, ... and sleep-disordered breathing medical devices and accessories. ... in China, combined with ResMed,s global leadership in sleep and respiratory ... China suffering from sleep-disordered ...
(Date:7/30/2015)... 2015  EP Global Communications, Inc. (Public OTC: EPGL) announced ... the Company about discussing EPGL,s electronic contact lens ... August 3, 2015.  Novartis CEO Joe Jimenez ... coming electronic contact lens market could be worth ... several years.  Novartis partnered with Google in 2014 ...
Breaking Medicine Technology:Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3
... Inc.,(Nasdaq: MEDX ) announced today interim ... hormone refractory prostate cancer (HRPC) demonstrating,dose-dependent T-cell ... anti-CTLA-4 antibody. These studies were done in,combination ... that stimulates the proliferation of white blood ...
... GAITHERSBURG, Md., April 15 MedImmune today announced,that ... a potential treatment,for patients with asthma, with the ... (MAb) targeting interleukin-13 (IL-13). One of the,studies is ... Australia designed to,assess the potential of the anti-IL-13 ...
Cached Medicine Technology:Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting 2Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting 3Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting 4MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13 2MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13 3
(Date:8/1/2015)... ... ... Phil Valentine – the Executive Director of Connecticut Community for Addiction Recovery (CCAR) – began ... and heading north. Since that day, Phil has hiked over 1400 miles in nine states. ... family. He visited CCAR and left an inspirational message to his staff: “You can ...
(Date:7/31/2015)... ... ... Bowl 50 will emanate from Levi’s Stadium in Santa Clara, CA on Sunday, February ... In the two weeks that separate the conference championships and the Super Bowl, there is ... will mark the 50th time it has been held and the festivities will take place ...
(Date:7/31/2015)... ... , ... The 2nd annual Ride to Fight On will start and end ... The Ride to Fight On is a cycling fundraiser that benefits the West Cancer ... and The University of Tennessee Health Science Center. A health and wellness festival featuring ...
(Date:7/31/2015)... Mountain View, CA (PRWEB) , ... July 31, 2015 , ... ... hand for the athletes, judges, media, and VIPs at the 2015 Vans US Open ... best-tasting organic coconut water that can claim “no added sugar” on the market, is ...
(Date:7/31/2015)... ... 2015 , ... Well-known for its unique pastries and delicious confections, Pastry Palace, ... designs, making life just a little bit sweeter for newlyweds. A family-owned business, the ... orders one. , The bakery provides a full line of custom wedding cakes. Brides ...
Breaking Medicine News(10 mins):Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2Health News:Pastry Palace of Las Vegas Announces It Is Now Offering Custom Wedding Cakes in Las Vegas 2
... use of dexamethasone early in the treatment of children ... childhood cancer, may help reduce the risk of relapse ... conference on Saturday, December 6, at 2:00 p.m., during ... Hematology in San Francisco, CA. Additional research will be ...
... Dec. 6 Purple Cowboy is a new wine that will,help ... National,Finals Rodeo in Las Vegas this month. , ... combination, but in terms of the,professional rodeo community,s commitment to end ... This year, Las Vegas will host the ultimate championship of ...
... Dutch Health Insurance System model, according to an article by ... Journal of Health Politics, Policy and Law . , ... University of Texas School of Public Health at Houston, co-authored ... the Netherlands and its possible lessons for the United States. ...
... many tumors can be left untreated, depending on man,s age ... prostate cancer may prompt an understandable feeling of dread, but ... disposal for tackling the disease, medical experts say. , There ... should be considered strongly when weighing various procedures. In fact, ...
... Dec. 5 Two new studies out this week add to ... associated with increased risk of adverse mental health effects. The two ... and the Journal of Psychiatric Research . Both had ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO ...
... understand the connection , , FRIDAY, Dec. 5 (HealthDay News) ... mental health and your respiratory health -- specifically asthma. ... were more likely to have asthma than those who ... report. , If you,re a person with both asthma ...
Cached Medicine News:Health News:Novel treatments show improvements in survival and response rates for leukemia and lymphoma 2Health News:Novel treatments show improvements in survival and response rates for leukemia and lymphoma 3Health News:Novel treatments show improvements in survival and response rates for leukemia and lymphoma 4Health News:Novel treatments show improvements in survival and response rates for leukemia and lymphoma 5Health News:Novel treatments show improvements in survival and response rates for leukemia and lymphoma 6Health News:The Days of Wine and Rodeo 2Health News:UT public health policy expert says US can learn from Dutch universal healthcare coverage 2Health News:Treatment Options Are Many for Prostate Cancer 2Health News:Treatment Options Are Many for Prostate Cancer 3Health News:Poor Mental Health May Boost Asthma Risk 2
... provides a versatile means of sectioning fresh ... The 1000 employs a vibrating blade principle ... The creation of artifacts, the alteration ... and other deleterious effects inherent in freezing ...
... The NEW Vibratome 3000 Deluxe Sectioning ... fresh or fixed, animal, or plant tissues. ... principle which allows sectioning without freezing or ... alteration of morphology, the destruction of enzyme ...
... The NEW Vibratome 3000 Plus Sectioning ... fresh or fixed, animal, or plant tissues. ... principle which allows sectioning without freezing or ... alteration of morphology, the destruction of enzyme ...
... The Vibratome 1000 Plus Sectioning System ... or fixed, animal, or plant tissues. ... which allows sectioning without freezing or embedding. ... of morphology, the destruction of enzyme activities, ...
Medicine Products: